An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and potential immune
response of AMG 167 following multiple subcutaneous (SC, injection under the skin) dose
administrations in healthy men and postmenopausal women with low bone mineral density.